Discover how abelacimab reduces bleeding risks in AFib patients by effectively lowering free factor XI levels.

THURSDAY, Jan. 23, 2025 -- Subcutaneous injection of abelacimab results in lower levels of free factor XI and significantly fewer bleeding events...

Researchers have found that Factor XI inhibitors, such as abelacimab, reduce bleeding risks in atrial fibrillation patients more effectively than...

Patients with atrial fibrillation are often prescribed blood thinners, or medlinkanticoagulants/medlink, to lower their medlinkstroke risk/medlink,

THURSDAY, Feb. 6, 2025 -- The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only...

A new study has found that prescribing blood thinners to adults under 65 with atrial fibrillation (AFib) but no other health risks does not help...

A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating older patients with...

Exelixis, Inc., a globally ambitious oncology company, announced results from a subgroup analysis of the phase 3 CABINET pivotal study of patients...

A new study suggests that certain substances in the blood may help identify people with a type of irregular heartbeat called atrial fibrillation...

An analysis conducted at the district level by the Education Ministry shows that the Year 8 failure rate has increased, potentially due to a lack of...